The Rare Moments

See what’s been shared

That’s a wrap for now!

This feed is no longer active or accepting submissions, but we encourage you to check out the posts below which were submitted during February 2024 in support of Rare Disease Day.

Updated 2 months ago
Dave Bowser Admin Dave Bowser Worldwide Clinical Trials

I’m amazed with the technologies used to treat patients living with a rare disease, including gene-based therapeutics. These drugs often target the underlying cause of the disease. One example of this is Casgevy, which was approved to treat patients with sickle cell disease in December 2023 and was recently approved for patients with beta-thalassemia in January 2024. I look forward to seeing more of these treatments throughout 2024.

www.fiercepharma.com/pharma/vertex-crispr-win-early-fda-nod-gene-therapy-casgevy-treat-beta-thalassemia
Téa Romero Téa Romero Scout Clinical

My son was born with the disease biliary atresia, a serious and life-threatening disease in which babies are born with an abnormal opening in their bile ducts, either outside or inside the liver. BA is rare and only affects 1 out of every 18,000 infants, according to the NIH website. Without treatments, surgery, or transplants, the infants with BA are unlikely to live past the age of 2 years. My son received his life-saving liver transplant as an infant. The follow-up biopsy appointments, regular blood draws, and a scary time post-transplant with elevated EBV, there have been so many ups and downs. A short time ago, we were unsure where his path would lead. We had to do school from home, and his activities were limited. I am happy to share that my son is now in 3rd grade. He is doing well academically, and he’s playing soccer on a club team. He’s living a happy and active life thanks to a care team that included many doctors, nurses, patient advocates, and the pharmaceutical drugs that keep him healthy.

www.linkedin.com/posts/tearomeromba_rarediseaseday2021-biliaryatresia-activity-6771818075999264768-mySk?utm_source=share&utm_medium=member_desktop
Sara Davis Admin Sara Davis Worldwide Clinical Trials

The number of rare disease clinical trials increases every year. Not only are these trials getting more and more complex, but the mode of administration is often very challenging. In December 2023, the FDA released its guidance document entitled Rare Diseases: Considerations for the Development of Drugs and Biological Products. The comments from the FDA on the importance of engaging patients, caregivers, and their advocates in the drug development process is something we take very seriously at Worldwide.

www.fda.gov/regulatory-information/search-fda-guidance-documents/rare-diseases-considerations-development-drugs-and-biological-products
Valaree Machen Valaree Machen Uplifting Athletes

Working with the rare community is a privilege — being able to connect in-person is even better! I’m very excited to celebrate 10 early-career scientists who are passionate about rare research this Saturday, February 3, 2024, ahead of Rare Disease Day at Uplifting Athletes’ 2024 Young Investigator Draft. This year, Uplifting Athletes will also be celebrating surpassing their first $1 million of grant money funded!

charity.pledgeit.org/YID2024
Derek Ansel Admin Derek Ansel Worldwide Clinical Trials

We are so excited to launch Rare Moments, our website dedicated to sharing updates from the rare disease community throughout the week of Rare Disease Day. Please share your memories, notes, events, thoughts, and resources during this week so that we can help elevate each other’s voices. So much happens during Rare Disease Week, so favorite this page and visit often to stay current on all things Rare Disease!

1 2 3 4

We live for the rare moments.